Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients

It has been reported that certain patients with non-small-cell lung cancer (NSCLC) that harbor activating somatic mutations within the tyrosine kinase domain of the epidermal growth factor receptor (EGFR) gene may be effectively treated using targeted therapy. The use of EGFR inhibitors in patient t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncol Lett
Autors principals: PAPADOPOULOU, EIRINI, TSOULOS, NIKOLAOS, TSIRIGOTI, ANGELIKI, APESSOS, ANGELA, AGIANNITOPOULOS, KONSTANTINOS, METAXA-MARIATOU, VASILIKI, ZAROGOULIDIS, KONSTANTINOS, ZAROGOULIDIS, PAVLOS, KASARAKIS, DIMITRIOS, KAKOLYRIS, STYLIANOS, DAHABREH, JUBRAIL, VLASTOS, FOTIS, ZOUBLIOS, CHARALAMPOS, RAPTI, AGGELIKI, PAPAGEORGIOU, NIKI GEORGATOU, VELDEKIS, DIMITRIOS, GAGA, MINA, ARAVANTINOS, GERASIMOS, KARAVASILIS, VASILEIOS, KARAGIANNIDIS, NAPOLEON, NASIOULAS, GEORGE
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2015
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4579824/
https://ncbi.nlm.nih.gov/pubmed/26622815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.3600
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars